pH sensitive peptide functionalized nanoparticles for co-delivery of erlotinib and DAPT to restrict the progress of triple negative breast cancer

pH sensitive peptide functionalized nanoparticles for co-delivery of erlotinib and DAPT to restrict the progress of triple negative breast cancer

Although a variety of drug delivery strategies have been designed for enhancing the treatment of Triple negative breast cancer (TNBC), combating with TNBCs is still dramatically challenged by the selection of appropriate therapeutic targets and insufficient tumor accumulation or inner penetration of...

Full description

Bibliographic Details
Main Authors: Xu Wan, Chaoqian Liu, Yinan Lin, Jie Fu, Guohong Lu, Zhengmao Lu
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:Drug Delivery
Subjects:
triple negative breast cancer
erlotinib
gamma secretase inhibitor
tumor targeting
nanoaprticles
ph-sensitive
Online Access:http://dx.doi.org/10.1080/10717544.2019.1576801

Internet

http://dx.doi.org/10.1080/10717544.2019.1576801

Similar Items